John T. Slattery

9.2k total citations
132 papers, 6.9k citations indexed

About

John T. Slattery is a scholar working on Pharmacology, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, John T. Slattery has authored 132 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pharmacology, 24 papers in Hematology and 22 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in John T. Slattery's work include Pharmacogenetics and Drug Metabolism (29 papers), Drug-Induced Hepatotoxicity and Protection (28 papers) and Hematopoietic Stem Cell Transplantation (20 papers). John T. Slattery is often cited by papers focused on Pharmacogenetics and Drug Metabolism (29 papers), Drug-Induced Hepatotoxicity and Protection (28 papers) and Hematopoietic Stem Cell Transplantation (20 papers). John T. Slattery collaborates with scholars based in United States, Canada and China. John T. Slattery's co-authors include Sidney D. Nelson, Thomas F. Kalhorn, Kenneth E. Thummel, John P. Gibbs, Claudio Anasetti, Gerhard Levy, Anne M Lynn, Rainer Storb, Frederick R. Appelbaum and George B. McDonald and has published in prestigious journals such as JAMA, Blood and Hepatology.

In The Last Decade

John T. Slattery

132 papers receiving 6.6k citations

Peers

John T. Slattery
Jatinder K. Lamba United States
Daniel Deykin United States
Jogarao Gobburu United States
Celeste Lindley United States
Stuart A. Scott United States
Deanna L. Kroetz United States
John T. Slattery
Citations per year, relative to John T. Slattery John T. Slattery (= 1×) peers Victor W. Armstrong

Countries citing papers authored by John T. Slattery

Since Specialization
Citations

This map shows the geographic impact of John T. Slattery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John T. Slattery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John T. Slattery more than expected).

Fields of papers citing papers by John T. Slattery

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John T. Slattery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John T. Slattery. The network helps show where John T. Slattery may publish in the future.

Co-authorship network of co-authors of John T. Slattery

This figure shows the co-authorship network connecting the top 25 collaborators of John T. Slattery. A scholar is included among the top collaborators of John T. Slattery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John T. Slattery. John T. Slattery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Watkins, Paul B., Neil Kaplowitz, John T. Slattery, et al.. (2006). Aminotransferase Elevations in Healthy Adults Receiving 4 Grams of Acetaminophen Daily. JAMA. 296(1). 87–87. 447 indexed citations
2.
Nash, Richard A., Laura Johnston, Pablo Parker, et al.. (2005). A Phase I/II Study of Mycophenolate Mofetil in Combination with Cyclosporine for Prophylaxis of Acute Graft-versus-Host Disease after Myeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 11(7). 495–505. 95 indexed citations
3.
Kalhorn, Thomas F., et al.. (2005). A highly sensitive high-performance liquid chromatography–mass spectrometry method for quantification of fludarabine triphosphate in leukemic cells. Journal of Chromatography B. 820(2). 243–250. 14 indexed citations
4.
Qiu, Ruolun, Thomas F. Kalhorn, & John T. Slattery. (2004). ABCC2-Mediated Biliary Transport of 4-Glutathionylcyclophosphamide and Its Contribution to Elimination of 4-Hydroxycyclophosphamide in Rat. Journal of Pharmacology and Experimental Therapeutics. 308(3). 1204–1212. 28 indexed citations
5.
McCune, Jeannine S. & John T. Slattery. (2002). Pharmacological Considerations of Primary Alkylators. Cancer treatment and research. 112. 323–345. 4 indexed citations
6.
Deeg, H. Joachim, Barry E. Storer, John T. Slattery, et al.. (2002). Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome. Blood. 100(4). 1201–1207. 212 indexed citations
7.
Kalhorn, Thomas F., Song Ren, William N. Howald, Ross F. Lawrence, & John T. Slattery. (1999). Analysis of cyclophosphamide and five metabolites from human plasma using liquid chromatography–mass spectrometry and gas chromatography–nitrogen–phosphorus detection. Journal of Chromatography B Biomedical Sciences and Applications. 732(2). 287–298. 37 indexed citations
8.
Slattery, John T. & Linda J. Risler. (1998). Therapeutic Monitoring of Busulfan in Hematopoietic Stem Cell Transplantation. Therapeutic Drug Monitoring. 20(5). 543–549. 102 indexed citations
9.
Lee, Caroline A., et al.. (1996). Effects of caffeine and theophylline on acetaminophen pharmacokinetics: P450 inhibition and activation.. Journal of Pharmacology and Experimental Therapeutics. 277(1). 287–291. 20 indexed citations
10.
Thummel, Kenneth E., et al.. (1996). Inhibition of sulfamethoxazole hydroxylamine formation by fluconazole in human liver microsomes and healthy volunteers*. Clinical Pharmacology & Therapeutics. 59(3). 332–340. 39 indexed citations
11.
Lynn, Anne M, Mary Kay Nespeca, Kent E. Opheim, & John T. Slattery. (1993). Respiratory Effects of Intravenous Morphine Infusions in Neonates, Infants, and Children After Cardiac Surgery. Anesthesia & Analgesia. 77(4). 695???701–695???701. 115 indexed citations
12.
Thomassen, David G., et al.. (1992). Reactive intermediates in the oxidation of menthofuran by cytochromes P-450. Chemical Research in Toxicology. 5(1). 123–130. 46 indexed citations
13.
Thummel, Kenneth E., et al.. (1991). Activation of acetaminophen-reactive metabolite formation by methylxanthines and known cytochrome P-450 activators.. Drug Metabolism and Disposition. 19(5). 966–971. 10 indexed citations
14.
Slattery, John T., T F Kalhorn, & Kenneth E. Thummel. (1991). Mechanisms by which acetaminophen administration diminishes ethanol clearance.. Drug Metabolism and Disposition. 19(2). 558–560. 2 indexed citations
15.
Hutabarat, Renta, et al.. (1991). Disposition of drugs in cystic fibrosis. III. Acetaminophen. Clinical Pharmacology & Therapeutics. 50(6). 695–701. 24 indexed citations
16.
McClanahan, Robert H., David G. Thomassen, John T. Slattery, & Sidney D. Nelson. (1989). Metabolic activation of (R)-(+)-pulegone to a reactive enonal that covalently binds to mouse liver proteins. Chemical Research in Toxicology. 2(5). 349–355. 59 indexed citations
17.
Slattery, John T., et al.. (1989). Lack of effect of cimetidine on acetaminophen disposition in humans. Clinical Pharmacology & Therapeutics. 46(5). 591–597. 24 indexed citations
18.
Thomassen, David G., John T. Slattery, & Sidney D. Nelson. (1988). Contribution of menthofuran to the hepatotoxicity of pulegone: assessment based on matched area under the curve and on matched time course.. Journal of Pharmacology and Experimental Therapeutics. 244(3). 825–829. 52 indexed citations
19.
Slattery, John T., et al.. (1987). Dose-dependent pharmacokinetics of acetaminophen: Evidence of glutathione depletion in humans. Clinical Pharmacology & Therapeutics. 41(4). 413–418. 114 indexed citations
20.
Slattery, John T. & Gerhard Levy. (1979). Determination of naproxen and its desmethyl metabolite in human plasma or serum by high performance liquid chromatography. Clinical Biochemistry. 12(3). 100–103. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026